<?xml version="1.0" encoding="UTF-8"?>
<p>In summary, production studies by our laboratory have successfully developed upstream process for plant biomass generation, infiltration and robust NoV VLP accumulation, and a novel downstream process for efficiently recovering VLPs from plant tissue [
 <xref ref-type="bibr" rid="CR0008126">126</xref>]. Moreover, these processes have been successfully operated under cGMP regulations and produced high-quality VLPs that meet all preset release specifications in identity, purity, potency, and safety [
 <xref ref-type="bibr" rid="CR0008126">126</xref>]. Hence, these studies provide the first precedent in an academic setting of producing a plant-derived vaccine at scale and under cGMP regulations and are an important step for plant-produced NoV VLP vaccines to become a commercial reality.
</p>
